Bad Dürkheim, Germany

Michaela Opitz



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michaela Opitz: Innovator in Pharmaceutical Technology

Introduction

Michaela Opitz is a prominent inventor based in Bad Dürkheim, Germany. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative pellet formulations. With a total of 2 patents, her work focuses on enhancing the efficiency and effectiveness of drug delivery systems.

Latest Patents

Michaela's latest patents include "Rapidly disintegrating coated pellets with delayed release" and "Fast decomposing pellets." Both inventions concern pharmaceutical forms of administration in the form of pellets that contain a retarding agent. The unique aspect of these pellets is that the release rate of the active substance is not delayed or is substantially identical compared to corresponding pellets that do not contain a retarding agent. Notably, the release rate of these rapidly disintegrating pellets is at least about 90% within a time period of 30 minutes. Additionally, her patents also cover processes for the production of these innovative pellets.

Career Highlights

Michaela Opitz is currently associated with Roche Diagnostics GmbH, where she continues to push the boundaries of pharmaceutical innovation. Her work has been instrumental in developing new methods for drug delivery that improve patient outcomes.

Collaborations

Michaela has collaborated with notable colleagues such as Rolf-Dieter Gabel and Geoffrey Lee, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Michaela Opitz stands out as a key figure in the pharmaceutical industry, with her innovative patents paving the way for advancements in drug delivery systems. Her contributions are vital for improving the efficacy of medications and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…